How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21489
Abstract: Thrombotic thrombocytopenic purpura (TTP) is a rare disease with 90% mortality if untreated. Since the Canadian Apheresis Group (CAG) trial showed greater survival with therapeutic plasma exchange (TPE) versus plasma infusion, there has been widespread… read more here.
Keywords: survey; thrombotic thrombocytopenic; practice; thrombocytopenic purpura ... See more keywords
How I treat thrombotic microangiopathy in the era of rapid genomics.
Sign Up to like & getrecommendations! Published in 2022 at "Blood"
DOI: 10.1182/blood.2022015583
Abstract: Thrombotic microangiopathy (TMA) encompasses various genetically driven diseases. The emergence of ultra-fast genomic sequencing has recently opened up new avenues of research for genetic investigations in the setting of intensive care units. TMA is likely… read more here.
Keywords: thrombotic microangiopathy; treat thrombotic; genomic sequencing; fast track ... See more keywords